<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-08T11:20:53+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>在线课堂 |【第41期】经验论述药企授权合作——剖析创新药企国际化战略手段</title>
    <updated>2020-12-07T19:25:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/a9_7o2oshoX3uvAqmvu6dA</id>
    <link href="https://mp.weixin.qq.com/s/a9_7o2oshoX3uvAqmvu6dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK首款儿童红斑狼疮创新疗法获批；前新基中国总经理入职亚盛医药；三款新冠疫苗进入江苏采购计划</title>
    <updated>2020-12-07T19:25:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/6WKK5CSaW2tqCSEEpkJVXQ</id>
    <link href="https://mp.weixin.qq.com/s/6WKK5CSaW2tqCSEEpkJVXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 迪英加获得近亿元B1轮投资；​基因宝获数千万元人民币A+轮融资</title>
    <updated>2020-12-07T19:25:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/CP0IvuGN0YhNKM09WKMykw</id>
    <link href="https://mp.weixin.qq.com/s/CP0IvuGN0YhNKM09WKMykw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进双特异性抗体新药获批；诺和诺德使用优先审评券，向FDA提交减肥适应症上市申请；杨森买下基因疗法，加强自身眼部疾病管线</title>
    <updated>2020-12-06T18:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/TKWXL3OYeMIzoVT-CkVcpQ</id>
    <link href="https://mp.weixin.qq.com/s/TKWXL3OYeMIzoVT-CkVcpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田达泽优获批进入中国，填补国内HAE长期无针对性治疗空白</title>
    <updated>2020-12-06T18:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/jw2ltnai2nCvkPUMq8_EvA</id>
    <link href="https://mp.weixin.qq.com/s/jw2ltnai2nCvkPUMq8_EvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 江苏省公布第四轮公立医疗机构耗材带量采购结果；永胜医疗收购VMHK及VMDG的其余股本权益</title>
    <updated>2020-12-06T18:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/3Im5J6mNp9yZX4l6mIK_-A</id>
    <link href="https://mp.weixin.qq.com/s/3Im5J6mNp9yZX4l6mIK_-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判倒计时！| 21个国产1类新药，最终花落谁家？</title>
    <updated>2020-12-03T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/mGGY1Fouw0gnQF6c_Qa68Q</id>
    <link href="https://mp.weixin.qq.com/s/mGGY1Fouw0gnQF6c_Qa68Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BMS在中国递交新适应症上市申请；阿斯利康出售可定欧洲权益；百济神州获批临床；辉瑞/BioNTech新冠疫苗获英国紧急使用授权</title>
    <updated>2020-12-03T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/_XP4r--ovO0nUE7n6pPygQ</id>
    <link href="https://mp.weixin.qq.com/s/_XP4r--ovO0nUE7n6pPygQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>23家药企 Q3业绩大公布！美敦力、飞利浦、强生......</title>
    <updated>2020-12-03T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Dhre4IvICwAgWut6Qno1Tw</id>
    <link href="https://mp.weixin.qq.com/s/Dhre4IvICwAgWut6Qno1Tw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判倒计时 | 21个国产1类新药，最终花落谁家？</title>
    <updated>2020-12-02T23:50:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/1hJpAdYfLX2rM9B7jPPTww</id>
    <link href="https://mp.weixin.qq.com/s/1hJpAdYfLX2rM9B7jPPTww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物和礼来合作开发的双抗药获批临床；亚盛医药联合治疗激发“合成致死”机制；药明康德联手ViGeneron深耕眼科</title>
    <updated>2020-12-02T23:50:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/yGQPB2gk1B-1BaWrGJiEXg</id>
    <link href="https://mp.weixin.qq.com/s/yGQPB2gk1B-1BaWrGJiEXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 医用耗材国采平台年底建成；首款PSMA靶向PET成像药物获批</title>
    <updated>2020-12-02T23:50:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/AdRcyhDPrXp8MIlXGiOMFQ</id>
    <link href="https://mp.weixin.qq.com/s/AdRcyhDPrXp8MIlXGiOMFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤年报 (一) | 聚焦县域 非小细胞肺癌市场分析</title>
    <updated>2020-12-01T21:56:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/JJgywX0XWF7yiYaItztV2w</id>
    <link href="https://mp.weixin.qq.com/s/JJgywX0XWF7yiYaItztV2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>广东55个药品集采尘埃落定 最高降幅达97%;赛诺菲/再生元宣布获欧盟批准;Kadmon公司宣布获FDA批准</title>
    <updated>2020-12-01T21:56:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/eW0f7Fip6ZQDy1OrrdqRNQ</id>
    <link href="https://mp.weixin.qq.com/s/eW0f7Fip6ZQDy1OrrdqRNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 广东拟与六省结盟对冠脉球囊杀价；重磅！人工智能精准预测蛋白质结构</title>
    <updated>2020-12-01T21:56:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/kQcoMQErzIVtGzuMYPRkHA</id>
    <link href="https://mp.weixin.qq.com/s/kQcoMQErzIVtGzuMYPRkHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>叮！20款药 上海黄线警告</title>
    <updated>2020-11-30T23:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/Xvtb5TFcG0q8oqg1334b3A</id>
    <link href="https://mp.weixin.qq.com/s/Xvtb5TFcG0q8oqg1334b3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>撤销药店开办设定的间距限制；首个治疗特定基因缺陷引起的肥胖症新药获FDA批准；渤健达成研发合作开发突破性抑郁症和运动障碍疗法</title>
    <updated>2020-11-30T23:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/6_8WBER2qHAJJseOkT0a1A</id>
    <link href="https://mp.weixin.qq.com/s/6_8WBER2qHAJJseOkT0a1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 上海凯利泰金属锁定接骨板钉系统产品获菲律宾注册证；心脏介入器械企业科凯生命科学完成数亿元B轮融资</title>
    <updated>2020-11-30T23:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/MymbBRFypJAXhofmzsneJQ</id>
    <link href="https://mp.weixin.qq.com/s/MymbBRFypJAXhofmzsneJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GBI英文期刊 | 专利悬崖进入中国？专利管理寻求新的利益平衡模式</title>
    <updated>2020-11-29T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/Z5ZzhpS1RhHTfPn8F3D2fQ</id>
    <link href="https://mp.weixin.qq.com/s/Z5ZzhpS1RhHTfPn8F3D2fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东抗艾滋病药获批；修美乐全球首次获批新适应症；拜耳首创新药获III期临床最新数据；IDT中国成立，深耕基因组学和核酸产品</title>
    <updated>2020-11-29T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/UAV1TT2gf7zu9GtKPl9OCQ</id>
    <link href="https://mp.weixin.qq.com/s/UAV1TT2gf7zu9GtKPl9OCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>